Danaher Corporation (DHR) stock: analyst price target and their real reliability
Live quote · data updated Oct 14, 2026
Danaher Corporation · Health Care · ref. ETF XLV · 60 calls · price $222.84
What the company does: Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
📈 Danaher Corporation (DHR) stock price
$222.84+8.1% over range
Oct 14, 25low $161.91 · high $242.05Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
77% recommend buying · 13 analysts
📊 JPI status : Danaher Corporation has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 DHR price target & analyst consensus — price $223
The price target · all analysts combined (13 targets)
Highest target · 2 firms of 13$255+14.4%
Median target · of 13 targets$230+3.2%
Lowest target · 1 firm of 13$95-57.4%
Current price$222.84
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
969%
$230 ↔ $255
Below
431%
$95 ↔ $220
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Stifel — 68% of its targets hit on this sector (304 calls tested). It aims for $220 (-1.3 %), call made on July 23, 2026, maturing on July 23, 2027 (83 d ago).
The 4 reliable analysts
$235+5.4 %
The 9 other firms
$240+7.7 %
How to read it: the 4 reliable firms are not filtered by optimism — 2 aim above the price, 2 below, hence their $235 median. “The 9 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy1077%
Hold323%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 DHR price target all
All 60 calls, one by one, with our verdict on each firm.
→ See all 60 targets, analyst by analyst💡 The best analysts on DHR most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in DHR? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Danaher Corporation? The JPI assistant answers using our backtest data.
💰 Danaher Corporation dividend: yield, history & growth › open the full page
0.74%annual yield
📈 Steady dividend — 8 yrs of consecutive dividend increases
That's ~$1.44 per share per year.
📈 Danaher Corporation fundamentals: valuation, margins & growth › open the full page
P/E 39.7Net margin 15.9 %Revenue growth +5.5 %Cheap for the growth
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 23 %
2023
Rev −24%Profit −33%
2024
Rev −0%Profit −18%
2025
Rev +3%Profit −7%
🔎 Detailed analyses
🏛️ Which US Congress members hold Danaher Corporation (DHR)?
8 Congress members have disclosed DHR buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
Susie Lee 2× · 43%Cindy Axne 2× · 57%Dean Phillips 1× · 39%Kevin Hern 1× · 48%Kathy Manning 1× · 43%Dan Newhouse 1× · 33%Thomas Kean 1×Greg Stanton 1× · 48%
✅ Historical analyst reliability on DHR
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Needham ↗ | 100% | +50.6% | 5 |
| Morgan Stanley ↗ | 100% | +26.0% | 12 |
| ISI Group | 100% | +23.4% | 3 |
| B of A Securities ↗ | 83% | +29.0% | 6 |
| Citigroup ↗ | 82% | +26.7% | 17 |
| Stifel ↗ | 80% | +10.4% | 5 |
| Wells Fargo ↗ | 75% | +23.9% | 8 |
| Jefferies ↗ | 75% | +18.1% | 8 |
| Deutsche Bank ↗ | 75% | +16.4% | 4 |
| Credit Suisse | 73% | +17.5% | 11 |
See the other 15 firms
| Stephens & Co. ↗ | 0% | -16.3% | 2 |
| Benchmark ↗ | 0% | -10.3% | 2 |
| Guggenheim ↗ | 0% | -6.3% | 2 |
| Evercore ISI Group ↗ | 25% | -9.3% | 4 |
| TD Cowen ↗ | 25% | -8.4% | 4 |
| RBC Capital ↗ | 38% | +4.3% | 16 |
| UBS ↗ | 44% | +10.1% | 9 |
| Bernstein ↗ | 50% | +2.2% | 2 |
| Baird ↗ | 50% | +3.2% | 14 |
| Keybanc ↗ | 50% | +5.2% | 8 |
| Cowen & Co. | 50% | +6.4% | 2 |
| Raymond James ↗ | 57% | +10.1% | 7 |
| Barclays ↗ | 64% | +7.5% | 33 |
| Goldman Sachs ↗ | 67% | +13.1% | 3 |
| JP Morgan ↗ | 70% | +12.4% | 10 |
📊 What $1,000 invested in Danaher Corporation would be worth › open the full page
In short — $1,000 invested in Danaher Corporation 10 years ago would be worth $3,175 today, i.e. +12%/yr on average. Best year: 2020 (+52%), worst: 2024 (-18%). Price performance, excluding dividends.
If I'd invested $1,000 in Danaher Corporation
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $917 | -8% |
| 3 years ago | $868 | -13% |
| 5 years ago | $978 | -2% |
Return by year (Danaher Corporation)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -10% | $904 (-10%) |
| 2025 | +1% | $917 (-8%) |
| 2024 | -18% | $752 (-25%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Danaher Corporation
Loading news…
📋 All analyst calls on DHR
Filtered on — · ✕ show all
Morgan Stanley ↗
Oct 13, 26
▲ Overweight · 🎯$240
Today : $222.84 — upside +8%
🎯 on DHR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Buy · 🎯$255
Today : $222.84 — upside +14%
🎯 on DHR : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 13, 27
matures : Oct 13, 27
▲ Overweight · 🎯$255
Price at call : $217.46 — upside +17%
Today : $222.84 — upside +14%
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 7, 27
matures : Oct 7, 27
RBC Capital ↗
Oct 5, 26
▲ Outperform · 🎯$250
Price at call : $221.21 — upside +13%
Today : $222.84 — upside +12%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Oct 5, 27
matures : Oct 5, 27
Guggenheim ↗
Oct 1, 26
▲ Buy · 🎯$250
Price at call : $214.06 — upside +17%
Today : $222.84 — upside +12%
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Oct 1, 27
matures : Oct 1, 27
Wells Fargo ↗
Jul 22, 26
■ Equal-Weight neutral · not a buy · 🎯$195
Price at call : $192.5 — gap to target +1%
Today : $222.84 — gap to target -12%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
▲ Buy · 🎯$236
Price at call : $192.5 — upside +23%
Today : $222.84 — upside +6%
🎯 on DHR : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
▲ Buy · 🎯$220
Price at call : $192.5 — upside +14%
Today : $222.84 — upside -1%
🎯 on DHR : no call matured yet · 📊 on Health : 50.7% · +7.8% (304 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
See the other 52 calls, newest to oldest
Guggenheim ↗
Jul 22, 26
▲ Buy · 🎯$200
Price at call : $192.5 — upside +4%
Today : $222.84 — upside -10%
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
RBC Capital ↗
Jul 22, 26
▲ Outperform · 🎯$215
Price at call : $192.5 — upside +12%
Today : $222.84 — upside -4%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
in progress (365j)
matures : Jul 22, 27
matures : Jul 22, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$230
Price at call : $194.19 — upside +18%
Today : $222.84 — upside +3%
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
Piper Sandler ↗
Jun 11, 26
■ Neutral neutral · not a buy · 🎯$200
Price at call : $180.79 — gap to target +11%
Today : $222.84 — gap to target -10%
🎯 on DHR : no call matured yet · 📊 on Health : 46.6% · -1.4% (324 calls)
in progress (365j)
matures : Jun 11, 27
matures : Jun 11, 27
▲ Buy · 🎯$230
Price at call : $186.64 — upside +23%
Today : $222.84 — upside +3%
🎯 on DHR : no call matured yet · 📊 on Health : 55.2% · +1.7% (29 calls)
in progress (365j)
matures : Jun 3, 27
matures : Jun 3, 27
■ Neutral neutral · not a buy · 🎯$95
Price at call : $180.63 — gap to target -47%
Today : $222.84 — gap to target -57%
🎯 on DHR : no call matured yet · 📊 on Health : 53.1% · +2.4% (516 calls)
in progress (365j)
matures : May 27, 27
matures : May 27, 27
Morgan Stanley ↗
Apr 23, 26
▲ Overweight · 🎯$255
Price at call : $177.25 — upside +44%
Today : $222.84 — upside +14%
🎯 on DHR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Apr 23, 27
matures : Apr 23, 27
▲ Buy · 🎯$250
Price at call : $178.57 — upside +40%
Today : $222.84 — upside +12%
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Wells Fargo ↗
Apr 22, 26
■ Equal-Weight neutral · not a buy · 🎯$212
Price at call : $178.57 — gap to target +19%
Today : $222.84 — gap to target -5%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
Guggenheim ↗
Apr 22, 26
▲ Buy · 🎯$235
Price at call : $178.57 — upside +32%
Today : $222.84 — upside +5%
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Outperform · 🎯$245
Price at call : $184.04 — upside +33%
Today : $222.84 — upside +10%
🎯 on DHR : 33% (3 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 22, 27
matures : Apr 22, 27
▲ Outperform · 🎯$249
Price at call : $194.75 — upside +28%
Today : $222.84 — upside +12%
🎯 on DHR : 33% (3 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
in progress (365j)
matures : Apr 17, 27
matures : Apr 17, 27
▲ Overweight · 🎯$230
Price at call : $198.14 — upside +16%
Today : $222.84 — upside +3%
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Apr 14, 27
matures : Apr 14, 27
Goldman Sachs ↗
Apr 13, 26
▲ Buy · 🎯$230
Price at call : $198.61 — upside +16%
Today : $222.84 — upside +3%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$225
Price at call : $191.01 — upside +18%
Today : $222.84 — upside +1%
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
▲ Overweight · 🎯$275
Price at call : $218.89 — upside +26%
Today : $222.84 — upside +23%
🎯 on DHR : no call matured yet · 📊 on Health : 53.8% · +5.2% (364 calls)
in progress (365j)
matures : Jan 29, 27
matures : Jan 29, 27
▲ Buy · 🎯$265
Price at call : $218.89 — upside +21%
Today : $222.84 — upside +19%
🎯 on DHR : no call matured yet · 📊 on Health : 51.2% · +4.7% (383 calls)
in progress (365j)
matures : Jan 29, 27
matures : Jan 29, 27
▲ Buy · 🎯$270
Price at call : $235 — upside +15%
Today : $222.84 — upside +21%
🎯 on DHR : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
Guggenheim ↗
Jan 5, 26
▲ Buy · 🎯$275
Price at call : $236.59 — upside +16%
Today : $222.84 — upside +23%
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
in progress (365j)
matures : Jan 5, 27
matures : Jan 5, 27
Wells Fargo ↗
Dec 15, 25
■ Equal-Weight neutral · not a buy · 🎯$240
Price at call : $224.7 — gap to target +7%
Today : $222.84 — gap to target +8%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
Goldman Sachs ↗
Dec 9, 25
▲ Buy · 🎯$265
Price at call : $223.23 — upside +19%
Today : $222.84 — upside +19%
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
in progress (365j)
matures : Dec 9, 26
matures : Dec 9, 26
Morgan Stanley ↗
Dec 2, 25
▲ Overweight · 🎯$270
Price at call : $228.46 — upside +18%
Today : $222.84 — upside +21%
🎯 on DHR : no call matured yet · 📊 on Health : 51.6% · +5.2% (830 calls)
in progress (365j)
matures : Dec 2, 26
matures : Dec 2, 26
Wells Fargo ↗
Oct 23, 25
■ Equal-Weight neutral · not a buy · 🎯$230
Price at call : $222.73 — gap to target +3%
Today : $222.84 — gap to target +3%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Oct 23, 26
matures : Oct 23, 26
▲ Buy · 🎯$260
Price at call : $222.73 — upside +17%
Today : $222.84 — upside +17%
🎯 on DHR : no call matured yet · 📊 on Health : 48% · +0.6% (98 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
▲ Overweight · 🎯$250
Price at call : $218.1 — upside +15%
Today : $222.84 — upside +12%
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
in progress (365j)
matures : Oct 22, 26
matures : Oct 22, 26
Rothschild & Co
Oct 8, 25
■ Neutral neutral · not a buy · 🎯$220
Price at call : $204.96 — gap to target +7%
Today : $222.84 — gap to target -1%
🎯 on DHR : no call matured yet · 📊 unranked overall
in progress (365j)
matures : Oct 8, 26
matures : Oct 8, 26
Evercore ISI Group ↗
Oct 7, 25
▲ Outperform · 🎯$245
Price at call : $204.96 — upside +20%
Today : $222.84 — upside +10%
Expected +20% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
+6.1%
stock +6% · XLV +16%
matured Oct 7, 26
B of A Securities ↗
Sep 22, 25
▲ Buy · 🎯$220
Price at call : $189.72 — upside +16%
Today : $222.84 — upside -1%
Expected +16% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 100% (1 call matured) · 📊 on Health : 48.1% · +2.0% (362 calls)
+16.8%
stock +17% · XLV +23%
matured Sep 22, 26
▲ Buy · 🎯$225
Price at call : $202.81 — upside +11%
Today : $222.84 — upside +1%
Expected +11% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
-5.6%
stock -6% · XLV +20%
matured Jul 23, 26
Wells Fargo ↗
Jul 23, 25
■ Equal-Weight neutral · not a buy · 🎯$205
Price at call : $202.81 — gap to target +1%
Today : $222.84 — gap to target -8%
🎯 on DHR : no call matured yet · 📊 on Health : 47.6% · +1.0% (403 calls)
in progress (365j)
matures : Jul 23, 26
matures : Jul 23, 26
Guggenheim ↗
Jul 23, 25
▲ Buy · 🎯$250
Price at call : $197.89 — upside +26%
Today : $222.84 — upside +12%
Expected +26% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
-2.7%
stock -3% · XLV +18%
matured Jul 23, 26
▲ Outperform · 🎯$229
Price at call : $197.89 — upside +16%
Today : $222.84 — upside +3%
Expected +16% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 33% (3 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-2.7%
stock -3% · XLV +18%
matured Jul 23, 26
▲ Outperform · 🎯$226
Price at call : $190.05 — upside +19%
Today : $222.84 — upside +1%
Expected +19% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 33% (3 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
+5.8%
stock +6% · XLV +21%
matured Jul 18, 26
Scotiabank ↗
Jul 11, 25
▲ Sector Outperform · 🎯$275
Price at call : $204.85 — upside +34%
Today : $222.84 — upside +23%
Expected +34% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 33.3% · -8.8% (9 calls)
-2.3%
stock -2% · XLV +19%
matured Jul 11, 26
Evercore ISI Group ↗
Jul 8, 25
▲ Outperform · 🎯$226
Price at call : $200.68 — upside +13%
Today : $222.84 — upside +1%
Expected +13% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 50% (2 calls matureds) · 📊 on Health : 44.6% · -0.4% (186 calls)
-4.9%
stock -5% · XLV +20%
matured Jul 8, 26
▲ Overweight · 🎯$225
Price at call : $201 — upside +12%
Today : $222.84 — upside +1%
Expected +12% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-3.9%
stock -4% · XLV +16%
matured Jun 24, 26
RBC Capital ↗
Apr 23, 25
▲ Outperform · 🎯$250
Price at call : $196.5 — upside +27%
Today : $222.84 — upside +12%
Expected +27% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 42.8% · -2.5% (397 calls)
-9.8%
stock -10% · XLV +5%
matured Apr 23, 26
Goldman Sachs ↗
Apr 23, 25
▲ Buy · 🎯$240
Price at call : $196.5 — upside +22%
Today : $222.84 — upside +8%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (1 call matured) · 📊 on Health : 51.4% · +2.3% (243 calls)
-9.8%
stock -10% · XLV +5%
matured Apr 23, 26
Guggenheim ↗
Apr 23, 25
▲ Buy · 🎯$250
Price at call : $196.5 — upside +27%
Today : $222.84 — upside +12%
Expected +27% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 55.4% · +4.9% (101 calls)
-9.8%
stock -10% · XLV +5%
matured Apr 23, 26
▲ Buy · 🎯$240
Price at call : $196.5 — upside +22%
Today : $222.84 — upside +8%
Expected +22% · Actual -10% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 0% (2 calls matureds) · 📊 on Health : 51.7% · +3.1% (358 calls)
-9.8%
stock -10% · XLV +5%
matured Apr 23, 26
▲ Outperform · 🎯$225
Price at call : $196.31 — upside +15%
Today : $222.84 — upside +1%
Expected +15% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 33% (3 calls matureds) · 📊 on Health : 51.3% · +6.1% (302 calls)
-9.0%
stock -9% · XLV +8%
matured Apr 23, 26
▲ Overweight · 🎯$215
Price at call : $196.31 — upside +10%
Today : $222.84 — upside -4%
Expected +10% · Actual -9% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-9.0%
stock -9% · XLV +8%
matured Apr 22, 26
▲ Overweight · 🎯$205
Price at call : $180.76 — upside +13%
Today : $222.84 — upside -8%
Expected +13% · Actual +5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+4.9%
stock +5% · XLV +9%
matured Apr 10, 26
▲ Overweight · 🎯$215
Price at call : $193.68 — upside +11%
Today : $222.84 — upside -4%
Expected +11% · Actual +27% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+26.7%
stock +27% · XLV +19%
matured Oct 25, 24
▲ Overweight · 🎯$290
Price at call : $234.81 — upside +24%
Today : $222.84 — upside +30%
Expected +24% · Actual +15% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+15.0%
stock +15% · XLV +10%
matured Jul 25, 24
▲ Overweight · 🎯$260
Price at call : $206.09 — upside +26%
Today : $222.84 — upside +17%
Expected +26% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+19.3%
stock +19% · XLV +6%
matured Apr 25, 24
▲ Overweight · 🎯$270
Price at call : $220.73 — upside +22%
Today : $222.84 — upside +21%
Expected +22% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
+10.7%
stock +11% · XLV +10%
matured Apr 3, 24
▲ Overweight · 🎯$290
Price at call : $240.76 — upside +20%
Today : $222.84 — upside +30%
Expected +20% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-5.1%
stock -5% · XLV +4%
matured Jan 24, 24
▲ Overweight · 🎯$277
Price at call : $229.63 — upside +21%
Today : $222.84 — upside +24%
Expected +21% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-3.1%
stock -3% · XLV -4%
matured Nov 29, 23
▲ Overweight · 🎯$305
Price at call : $246.5 — upside +24%
Today : $222.84 — upside +37%
Expected +24% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-11.9%
stock -12% · XLV +4%
matured Oct 6, 23
▲ Overweight · 🎯$310
Price at call : $242.77 — upside +28%
Today : $222.84 — upside +39%
Expected +28% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on DHR : 42% (12 calls matureds) · 📊 on Health : 50.1% · +2.0% (645 calls)
-5.8%
stock -6% · XLV +5%
matured Jul 22, 23
Frequently asked questions
Should I buy Danaher Corporation stock?
This isn't buy advice. For Danaher Corporation, the analyst consensus is "Buy", with an average price target of $230 (+3% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (5 calls tracked on Danaher Corporation). We show the numbers — you decide.
Is it too late to buy Danaher Corporation? How high can it go?
The most bullish analyst target on Danaher Corporation is $255 (+14% above today's price); the average is $230. That's the upside they see. Check how reliable those analysts have actually been on Danaher Corporation on our site before trusting it.
Is Danaher Corporation still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 25 analysts have a real record on Danaher Corporation, the best hitting 100% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Danaher Corporation? The case for and against
The arguments for and against, one by one, from the numbers: why invest in DHR (and why hesitate).
What has Danaher Corporation's past performance been?
Historical returns and a "how much if I had invested" calculator: DHR performance & returns.
Does Danaher Corporation pay a dividend?
Yield, consistency and growth history of the dividend: DHR's dividend.
What is the best month to buy DHR?
The 12 months ranked by the stock's past returns: best & worst month to buy DHR.
BIIB 
VRTX 
REGN 
UNH 
EW 
SRPT 
VEEV 
BSX